GRAL was selected for funding as a Laboratoire d’excellence (Labex) through the “Investissements d’avenir” programme of the French government in 2011. GRAL’s funding has been extended until 2028 through the Chemistry, Biology and Health Graduate School of Université Grenoble Alpes.
The project is at the interface between structural and cellular biology, and is multidisciplinary by nature. Scientists, research staff, and students conduct forefront and innovative research in structural biology, cellular biology, integrative biology, plant biology, nanobiology, pathogenic-host interactions, cancer biology, molecular chemistry…
GRAL’s priorities are to decipher and integrate knowledge on the structure and dynamics of biological molecules and their function in the cellular context, in space and time.
The integrated approaches to address biological questions at different scales of resolution, analyzing their dynamics and function in vitro and in vivo model systems, will provide important results for basic science and will open up new opportunities in health, environment, and biotechnologies.
News
Arije Safa
Arije Safa works at the Structural Biology Institute Laboratory (IBS). Her project: The Structural Study of the nuclear export complex of mRNA Hello, my name is Arije SAFA, and I began my PhD on September 16, 2024, in the EPIGEN group at the Institute of Structural...
GRAL PhD projects 2025-2028 (7th call)
In the framework of the Chemistry, Biology, Health Graduate School (CBH-EUR-GS) of Université Grenoble Alpes, CBH Graduate School, Arcane Labex, and GRAL Labex have launched a common call to fund PhD projects. A researcher can only apply to one of the 3 funding...
GRAL PhD Operating Costs (5th call, 2024)
In the framework of the Chemistry Biology Health Graduate School (CBH-EUR-GS) of Université Grenoble Alpes, the Grenoble Alliance for Integrated Structural & Cell Biology (GRAL) funds operating costs for PhD projects conducted in GRAL labs: BioSanté, BGE, IBS,...
